The News Review:
- Doctor’s Work in Ultrasound Images Aids Drug Industry
- HIV drugs distribution ‘shameful failure’
- SHIL appoints chief and commercial head
Doctor’s Work in Ultrasound Images Aids Drug Industry
New York Times – Jul 22, 2007
z a well-known heart surgeon at NewYork-Presbyterian Hospital. The technology known as intravascular ultrasound or IVUS involves attaching miniature probes to the tip of a coronary catheter to create images of the inside of arteries. The information it reveals can help drug companies save money on clinical research by telling whether they are headed in the right direction with drugs under development. “As a first step you do IVUS” Dr. “If you show no difference you abandon ship.
HIV drugs distribution ‘shameful failure’
NEWS.com.au – Jul 22, 2007
"Together in six short years you have given hope to millions where none existed” Prof Kazatchkine said. "Let us now work to make hope a reality for the millions who are still waiting. ” Australian immunologist Professor David Cooper director of the National Centre in HIV Epidemiology and Clinical Research said Australia’s HIV rates were among the lowest in the industrialised world. Just 1000 people were infected annually compared with 4. 3 million worldwide. But infection rates were now increasing rapidly particularly in Victoria Western Australia and South Australia. Prof Cooper told the congress it was vital to focus on the best means of treatment and prevention rather than alienating those with the disease.
SHIL appoints chief and commercial head
Scotsman – Jul 22, 2007
Christie replaces Cameron Macdonald who has returned to industry becoming managing director of Controlled Therapeutics (Scotland) and vice-president of parent Cytokine Pharmaceuticals Philadelphia. Christie is a former executive of PPL Therapeutics the company co-responsible for Dolly the sheep. Nelson’s most recent role was as clinical research manager with Corin a UK orthopaedic company where he was closely involved in gaining government approval for Corin’s sale and use of its hip resurfacing product in the United States. The appointments follow the hiring of non-executive directors Colin Morgan of Johnson & Johnson Medical and Sandy Finlayson a senior partner at MBM Commercial. Peter Shakeshaft replaced fellow business angel Barry Sealey last year as chairman of SHIL which receives backing from the Executive as well as Scottish Enterprise Highland and Islands Enterprise the Department of Trade and Industry and the Chief Scientist ffice in Scotland. SHIL’s earliest big success was to back TouchEMAS now Touch Bionics the Livingston-based developer of the world’s most advanced bionic hand which has just been fitted to Scot Donald MacKillop who lost his right hand in an industrial accident nearly 30 years ago. ther recent successes include SHIL striking a deal with Active Ultrasonics a group of Swiss technology experts to help manufacture “The Mosquito” – a medical aid for cardiovascular operations – out of Tayside.
